Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Dynavax to Present at the Cowen and Company 33rd Annual Healthcare Conference


Print article Print article
© Marketwire 2013
2013-02-26 15:05:29 -

BERKELEY, CA -- (Marketwire) -- 02/26/13 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the Cowen and Company 33rd Annual Healthcare Conference in Boston on Tuesday, March 5, 2013 at 8:40 a.m. Eastern Time (5:40 a.m. Pacific Time).





Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a company overview. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at http://investors.dynavax.com/newsevents.cfm : investors.dynavax.com/newsevents.cfm .



About Dynavax



Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax's lead product candidate is HEPLISAV , a Phase 3 investigational adult hepatitis B vaccine. For more information visit www.dynavax.com : www.dynavax.com/ .




Contact:
Michael Ostrach
Vice President and Chief Business Officer
510-665-7257
Email Contact : www2.marketwire.com/mw/emailprcntct?id=4640BD8D36BAF1FB



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com